financetom
Business
financetom
/
Business
/
--Riley Exploration Permian Keeps Quarterly Dividend at $0.36 Per Share, Payable Aug. 8 to Shareholders of Record July 25
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Riley Exploration Permian Keeps Quarterly Dividend at $0.36 Per Share, Payable Aug. 8 to Shareholders of Record July 25
Jul 11, 2024 1:43 PM

04:19 PM EDT, 07/11/2024 (MT Newswires) --

Price: 29.57, Change: +0.08, Percent Change: +0.27

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Arcutis Biotherapeutics Q1 Loss Narrows as Revenue Surges; Shares Soar Premarket
Update: Arcutis Biotherapeutics Q1 Loss Narrows as Revenue Surges; Shares Soar Premarket
May 15, 2024
04:24 AM EDT, 05/15/2024 (MT Newswires) -- (Updates with the stock move in the headline and the first paragraph.) Arcutis Biotherapeutics' ( ARQT ) shares surged more than 20% in premarket activity on Wednesday after the company reported a narrower loss and handily beat market expectations for sales. The company reported a Q1 loss late Tuesday of $0.32 per diluted...
New York Community Bancorp to Sell $5 Billion in Mortgage Warehouse Loans to JPMorgan Chase Bank
New York Community Bancorp to Sell $5 Billion in Mortgage Warehouse Loans to JPMorgan Chase Bank
May 15, 2024
04:12 AM EDT, 05/15/2024 (MT Newswires) -- New York Community Bancorp ( NYCB/PU ) said Tuesday it has entered into a commitment letter to sell about $5 billion in mortgage warehouse loans to JPMorgan Chase Bank. The sale is expected to close in Q3. Shares of New York Community Bancorp gained almost 6% in after-market hours on Tuesday. Price: 4.1200,...
Biogen Partner Eisai Submits FDA Biologics Application for Early Alzheimer's Self-Injection Drug
Biogen Partner Eisai Submits FDA Biologics Application for Early Alzheimer's Self-Injection Drug
May 15, 2024
04:26 AM EDT, 05/15/2024 (MT Newswires) -- Biogen (BIIB) and Eisai said Tuesday that the latter has initiated a rolling submission of a biologics license application to the US Food and Drug Administration for lecanemab-irmb subcutaneous autoinjector as a weekly maintenance treatment for early Alzheimer's disease. The application came after the treatment, commercially known as Leqembi, was granted FDA fast-track...
Novonix Signs Testing, Development Deal With Volkswagen-Owned PowerCo
Novonix Signs Testing, Development Deal With Volkswagen-Owned PowerCo
May 15, 2024
04:32 AM EDT, 05/15/2024 (MT Newswires) -- Novonix ( NVX ) said late Tuesday it signed a non-exclusive testing and development agreement with Volkswagen-owned PowerCo to come up with synthetic graphite anode materials for electric vehicle batteries. The companies could later enter into a supply agreement for the products developed under the deal, Novonix ( NVX ) said. Financial terms...
Copyright 2023-2026 - www.financetom.com All Rights Reserved